Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder
NCT07480525Recruiting
- Sponsor
- Peking University
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Peking University. Primary endpoint: Hamilton Depression Rating Scale at 8 weeks. Started Mar 2026; status: recruiting.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07480525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07480525.